Table 1. Estimated chronic hepatitis B prevalence for the general population and key populations, Canada, 2021.
| Population | Population size estimate | Prevalence (%) | Estimated number of people living with CHB | Reference(s) | ||||
|---|---|---|---|---|---|---|---|---|
| Point estimate | Lower bound | Upper bound | Point estimate | Lower bound | Upper bound | |||
| General population | 38,239,864 | 0.68% | 0.40% | 0.97% | 262,000 | 152,000 | 371,000 | ((12,14,21–24)) |
| Immigrants from countries where HBV is common (HBsAg ≥2%) | 5,599,485 | 4.2% | 1.9% | 5.6% | 237,000 | 106,000 | 312,000 | ((21,25,26)) |
| GBMSM | 669,613 | 1.4% | 0.8% | 2.1% | 9,310 | 5,360 | 14,100 | ((27,28)) Unpublished data from the Engage cohort study, 2017–2019 |
| People incarcerated in federal prisonsa | 12,405 | 0.28% | 0.19% | 0.41% | 35 | 24 | 51 | Unpublished data from Correctional Service Canada, 2021 (personal communication, 2024) |
| People incarcerated in provincial prisonsb | Insufficient information | |||||||
| PWID | Insufficient information | |||||||
| First Nations | Insufficient information | |||||||
| Inuit | Insufficient information | |||||||
| Métis | Insufficient information | |||||||
Abbreviations: CHB, chronic hepatitis B; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; GBMSM, gay, bisexual and other men who have sex with men; PWID, people who inject drugs
a Who were sentenced for two years or more
b Who were sentenced for less than two years